Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q2 2025 · 10-Q
Revenue$11.19M$11.19M−2.8% vs Q2 2024 Net Income-$7.48M-$7.48MN/M vs Q2 2024 EPS Diluted-$14.15-$14.15N/M vs Q2 2024 Gross Profit$845,000−71.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,882,000N/M Margins · derivedGross margin7.6%−18.2 pt vs Q2 2024
Operating margin-60.2%−4.0 pt vs Q2 2024
Net margin-66.8%−9.4 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 8, 2025 · 39 d after period end